🇺🇸 FDA
Patent

US 8518870

Compositions and methods for cancer treatment using targeted carbon nanotubes

granted A61KA61K47/6929

Quick answer

US patent 8518870 (Compositions and methods for cancer treatment using targeted carbon nanotubes) held by The Board of Regents of the University of Oklahoma expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K47/6929